| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 11Z5AIU653 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Lysyl oxidase homolog 2 inhibitor | PubMed |
| Primary Target | |
|---|---|
| lysyl oxidase like 2 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cholangitis, Sclerosing | 2 | D015209 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 2 | D054990 | ClinicalTrials |
| Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
| Liver Cirrhosis | 2 | D008103 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1318075-13-6 |
| ChEMBL | CHEMBL2109667 |
| FDA SRS | 11Z5AIU653 |
| Guide to Pharmacology | 8412 |
CONTENTS